Silk Road Medical, Inc. (SILK): Price and Financial Metrics

Silk Road Medical, Inc. (SILK): $47.27

0.26 (+0.55%)

POWR Rating

Component Grades














  • Momentum is the dimension where SILK ranks best; there it ranks ahead of 49.3% of US stocks.
  • SILK's strongest trending metric is Value; it's been moving up over the last 31 weeks.
  • SILK ranks lowest in Value; there it ranks in the 21st percentile.

SILK Stock Summary

  • SILK's went public 2.18 years ago, making it older than only 4.8% of listed US stocks we're tracking.
  • With a price/sales ratio of 19.66, Silk Road Medical Inc has a higher such ratio than 89.91% of stocks in our set.
  • In terms of volatility of its share price, SILK is more volatile than merely 24.3% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Silk Road Medical Inc are AMSC, DRQ, AWH, CDXS, and ASPU.
  • SILK's SEC filings can be seen here. And to visit Silk Road Medical Inc's official web site, go to

SILK Price Target

For more insight on analysts targets of SILK, see our SILK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $67.50 Average Broker Recommendation 1.5 (Moderate Buy)

SILK Stock Price Chart Interactive Chart >

Price chart for SILK

SILK Price/Volume Stats

Current price $47.27 52-week high $75.80
Prev. close $47.01 52-week low $35.48
Day low $46.60 Volume 168,300
Day high $47.55 Avg. volume 364,033
50-day MA $51.12 Dividend yield N/A
200-day MA $57.57 Market Cap 1.63B

Silk Road Medical, Inc. (SILK) Company Bio

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

SILK Latest News Stream

Event/Time News Detail
Loading, please wait...

SILK Latest Social Stream

Loading social stream, please wait...

View Full SILK Social Stream

Latest SILK News From Around the Web

Below are the latest news stories about Silk Road Medical Inc that investors may wish to consider to help them evaluate SILK as an investment opportunity.

Silk Road Medical, Inc 2021 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Silk Road Medical, Inc in conjunction with their 2021 Q1 earnings call....

SA Transcripts on Seeking Alpha | May 14, 2021

Health Check: How Prudently Does Silk Road Medical (NASDAQ:SILK) Use Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Yahoo | May 12, 2021

Here’s Why Silk Road Medical Inc. (SILK) Landed in Wasatch Micro Cap’s Detractor List

Wasatch Global Investors, an investment management firm, published its “Wasatch Micro Cap Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 10.95% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell Microcap Index, which rose 23.89% for the same period. You can […]

Yahoo | May 10, 2021

SILK ROAD MEDICAL INC (SILK) Q1 2021 Earnings Call Transcript

Joining me are Erica Rogers, Chief Executive Officer; and Lucas Buchanan, Chief Financial Officer and Chief Operating Officer. Earlier today Silk Road Medical released financial results for the three months ended March 31st, 2021.

Yahoo | May 5, 2021

Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 22.50% and 3.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 4, 2021

Read More 'SILK' Stories Here

SILK Price Returns

1-mo -1.42%
3-mo -10.69%
6-mo -18.70%
1-year 27.34%
3-year N/A
5-year N/A
YTD -24.94%
2020 55.97%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7576 seconds.